Gyre Therapeutics (GYRE) Dividends Paid - Common (2023)
Gyre Therapeutics (GYRE) posted quarterly Dividends Paid - Common of $1.5 million for Q3 2023, down 57.14% quarter-over-quarter from $3.5 million in Q2 2023.
Gyre Therapeutics (GYRE) Dividends Paid - Common (2023) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Dividends Paid - Common for 1 consecutive years, with $1.5 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Dividends Paid - Common changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2023 stood at $12.8 million (changed N/A YoY), while the FY2022 annual figure was $45.0 million, changed N/A from the prior year.
- Dividends Paid - Common slipped to $1.5 million in Q3 2023 per GYRE's latest filing, from $3.5 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $7.8 million in Q1 2023 and bottomed at $1.5 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 7.76 Mn |
| Mar 31, 2023 | 7.76 Mn |